Atossa Therapeutics
ATOS
#10507
Rank
ยฃ17.66 M
Marketcap
ยฃ1.77
Share price
-2.07%
Change (1 day)
168.84%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -ยฃ27.97 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ26.1 Million a decrease over its 2024 earnings that were of -ยฃ19.14 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ27.97 Million7.16%
2025 -ยฃ26.1 Million36.33%
2024 -ยฃ19.14 Million-15.25%
2023 -ยฃ22.59 Million11.62%
2022 -ยฃ20.24 Million30.84%
2021 -ยฃ15.47 Million15.58%
2020 -ยฃ13.38 Million3.41%
2019 -ยฃ12.94 Million51.16%
2018 -ยฃ8.56 Million40.41%
2017 -ยฃ6.1 Million27.54%
2016 -ยฃ4.78 Million-47.49%
2015 -ยฃ9.11 Million-17.25%
2014 -ยฃ11 Million35.91%
2013 -ยฃ8.1 Million112.3%
2012 -ยฃ3.82 Million46.53%
2011 -ยฃ2.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.49 B-69,117.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
ยฃ1.03 B-3,755.59%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
ยฃ1.03 B-3,753.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
ยฃ31.27 M-210.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-ยฃ74.64 Million 164.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-ยฃ5.89 Million-79.17%๐Ÿ‡บ๐Ÿ‡ธ USA